These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 23756872

  • 1. Long-acting anticholinergics in the treatment of asthma.
    Guyer AC, Long AA.
    Curr Opin Allergy Clin Immunol; 2013 Aug; 13(4):392-8. PubMed ID: 23756872
    [Abstract] [Full Text] [Related]

  • 2. Anticholinergics for treatment of asthma.
    Quirce S, Domínguez-Ortega J, Barranco P.
    J Investig Allergol Clin Immunol; 2015 Aug; 25(2):84-93; quiz 94-5. PubMed ID: 25997301
    [Abstract] [Full Text] [Related]

  • 3. Tiotropium: a new therapeutic option in asthma.
    Novelli F, Costa F, Latorre M, Malagrinò L, Celi A, Vagaggini B, Paggiaro P.
    Monaldi Arch Chest Dis; 2013 Aug; 79(3-4):109-15. PubMed ID: 24761528
    [Abstract] [Full Text] [Related]

  • 4. Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial.
    Wechsler ME, Yawn BP, Fuhlbrigge AL, Pace WD, Pencina MJ, Doros G, Kazani S, Raby BA, Lanzillotti J, Madison S, Israel E, BELT Investigators.
    JAMA; 2015 Oct 27; 314(16):1720-30. PubMed ID: 26505596
    [Abstract] [Full Text] [Related]

  • 5. The emerging role of tiotropium for patients with asthma.
    Bollmeier SG, Lee SY.
    Ann Pharmacother; 2013 May 27; 47(5):704-13. PubMed ID: 23613100
    [Abstract] [Full Text] [Related]

  • 6. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety.
    Tashkin DP.
    Curr Opin Pulm Med; 2010 Mar 27; 16(2):97-105. PubMed ID: 20019615
    [Abstract] [Full Text] [Related]

  • 7. Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
    Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM, POET-COPD Investigators.
    N Engl J Med; 2011 Mar 24; 364(12):1093-1103. PubMed ID: 21428765
    [Abstract] [Full Text] [Related]

  • 8. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
    Tashkin DP.
    Expert Rev Respir Med; 2010 Jun 24; 4(3):279-89. PubMed ID: 20524910
    [Abstract] [Full Text] [Related]

  • 9. Tiotropium bromide as add-on therapy to inhaled corticosteroids for treating asthma.
    Matsuse H, Yamagishi T, Kodaka N, Miura A, Kurose Y, Nakano C, Oshio T.
    Expert Opin Pharmacother; 2015 Jun 24; 16(9):1403-9. PubMed ID: 26001185
    [Abstract] [Full Text] [Related]

  • 10. Safety and tolerability of once-daily tiotropium Respimat(®) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis.
    Dahl R, Engel M, Dusser D, Halpin D, Kerstjens HAM, Zaremba-Pechmann L, Moroni-Zentgraf P, Busse WW, Bateman ED.
    Respir Med; 2016 Sep 24; 118():102-111. PubMed ID: 27578478
    [Abstract] [Full Text] [Related]

  • 11. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug 24; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of inhaled tiotropium in asthma, uncontrolled with standard combination therapy.
    Antoniu SA, Antohe I.
    Expert Opin Pharmacother; 2013 May 24; 14(7):967-9. PubMed ID: 23514606
    [Abstract] [Full Text] [Related]

  • 13. Tiotropium Respimat®: A Review of Its Use in Asthma Poorly Controlled with Inhaled Corticosteroids and Long-Acting β2-Adrenergic Agonists.
    McKeage K.
    Drugs; 2015 May 24; 75(7):809-16. PubMed ID: 25895466
    [Abstract] [Full Text] [Related]

  • 14. Tiotropium bromide step-up therapy for adults with uncontrolled asthma.
    Peters SP, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, Boushey HA, Calhoun WJ, Castro M, Cherniack RM, Craig T, Denlinger L, Engle LL, DiMango EA, Fahy JV, Israel E, Jarjour N, Kazani SD, Kraft M, Lazarus SC, Lemanske RF, Lugogo N, Martin RJ, Meyers DA, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Wasserman SI, Walter MJ, Wechsler ME, Chinchilli VM, Bleecker ER, National Heart, Lung, and Blood Institute Asthma Clinical Research Network.
    N Engl J Med; 2010 Oct 28; 363(18):1715-26. PubMed ID: 20979471
    [Abstract] [Full Text] [Related]

  • 15. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma.
    Bateman ED, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM.
    J Allergy Clin Immunol; 2011 Aug 28; 128(2):315-22. PubMed ID: 21807250
    [Abstract] [Full Text] [Related]

  • 16. What is the role of tiotropium in asthma?: a systematic review with meta-analysis.
    Rodrigo GJ, Castro-Rodríguez JA.
    Chest; 2015 Feb 28; 147(2):388-396. PubMed ID: 25322075
    [Abstract] [Full Text] [Related]

  • 17. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
    Salama RO, Young PM, Rogueda P, Lallement A, Iliev I, Traini D.
    Expert Opin Pharmacother; 2011 Aug 28; 12(12):1913-32. PubMed ID: 21714776
    [Abstract] [Full Text] [Related]

  • 18. [The effect of inhaled anticholinergic drugs (tiotropium bromide) on asthma patients with persistent obstructive ventilatory impairment].
    Nogami H, Honjo S, Iwanaga T.
    Arerugi; 2012 Nov 28; 61(11):1675-82. PubMed ID: 23328224
    [Abstract] [Full Text] [Related]

  • 19. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.
    Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M, Uplift Investigators.
    Eur Respir J; 2010 Jul 28; 36(1):65-73. PubMed ID: 20185426
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.